Crossmark

Short-term dual anti-platelet therapy decreases long-term cardiovascular mortality after transcatheter aortic valve replacement

Published Online: 2020-09-03

Published Print: 2021-02

Authors

Hioki, Hirofumi https://orcid.org/0000-0001-7189-8450
Watanabe, Yusuke

Kozuma, Ken

Kataoka, Akihisa

Yashima, Fumiaki

Naganuma, Toru

Araki, Motoharu

Tada, Norio

Shirai, Shinichi

Yamanaka, Futoshi

Mizutani, Kazuki

Tabata, Minoru

Takagi, Kensuke

Ueno, Hiroshi

Yamamoto, Masanori

Hayashida, Kentaro

,
Funding

Funding for this research was provided by:

Daiichi-Sankyo

Edwards Lifesciences

Medtronic
License Information

Text and Data Mining valid from 2020-09-03

Version of Record valid from 2020-09-03
More Information

Article History

Received: 6 May 2020

Accepted: 28 August 2020

First Online: 3 September 2020

Compliance with ethical standards

:

: The OCEAN-TAVI registry is supported by Edwards-Lifesciences, Medtronic, and Daiichi-Sankyo company.

Document is current